Mei Luo
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Resistance in Bacteria 10
-
- Vibrio bacteria research studies 7
Mei Luo
96 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 152
- Molecular Medicine 206
- Applied Microbiology and Biotechnology 64
- Cancer Research 419
- Immunology 385
- Endocrinology 89
Countries citing papers authored by Mei Luo
This map shows the geographic impact of Mei Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mei Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mei Luo more than expected).
Fields of papers citing papers by Mei Luo
This network shows the impact of papers produced by Mei Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mei Luo. The network helps show where Mei Luo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mei Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 22 | |
| 7 | 2023 | 5 | |
| 8 | 2023 | 6 | |
| 9 | 2023 | 6 | |
| 10 | 2023 | 9 | |
| 11 | 2022 | 32 | |
| 12 | 2022 | 17 | |
| 13 | 2020 | 9 | |
| 14 | 2018 | 2 | |
| 15 | 2017 | 9 | |
| 16 | High-throughput discovery of SSR genetic markers in the mealybug, Phenacoccus solenopsis (Hemiptera: Pseudococcidae), from its transcriptome database. | 2014 | 6 |
| 17 | Molecular cloning, prokaryotic expression and expression at different developmental stages of cathepsin B gene in mealybug Phenacoccus solenopsis Tinsley (Hemiptera: Pseudococcidae). | 2012 | 1 |
| 18 | Involvement of NGOs in AIDS Global Fund Programs | 2007 | 1 |
| 19 | Treatment of combined blood-raising and wind-dispelling method and SAMe for intrahepatic cholestasis of pregnancy | 2005 | 1 |
| 20 | Surveying and evaluating ethical review practice | 2004 | 9 |
About Mei Luo
Mei Luo is a scholar working on Molecular Medicine, Endocrinology, Cancer Research, Molecular Biology and Applied Microbiology and Biotechnology, having authored 102 papers that have together received 2.2k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (10 papers), RNA modifications and cancer (7 papers), Vibrio bacteria research studies (7 papers), Epigenetics and DNA Methylation (7 papers), Cancer Immunotherapy and Biomarkers (5 papers), Cancer-related molecular mechanisms research (5 papers), Gut microbiota and health (5 papers) and Bacterial biofilms and quorum sensing (4 papers). The work is most often cited by research in Molecular Medicine (206 citations), Applied Microbiology and Biotechnology (64 citations), Cancer Research (419 citations), Immunology (385 citations) and Endocrinology (89 citations). Mei Luo has collaborated with scholars based in China, United States and Macao. Frequent co-authors include An‐Yuan Guo, Ya‐Ru Miao, Qiong Zhang, Gui‐Yan Xie, Qian Lei, Hongxiang Wang, Liu Pin, Mengxuan Xia, Jingfu Qiu and Wenyong Long. Their work appears in journals such as Nature Communications, Molecular Therapy — Nucleic Acids, PLoS ONE, Frontiers in Immunology and Journal of Neuro-Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.